TrialThe oncologist2018

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG).

Germán Reyes-Botero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.